Physical Activity for Myeloma Autograft Longitudinal Study
NCT ID: NCT03946332
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2019-05-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population
NCT01910753
Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
NCT00554489
Relaxation and Exercise In Lymphoma Patients
NCT02272751
Assessment and Modulation of Energy Balance in Cachectic Patients Using Adapted Physical Activity
NCT06645067
Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase
NCT01795612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the experimental arm, patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization. Furthermore, SMS will be regularly sent to remind them to practice. In the controlled arm, patients will be hospitalized in the same conditions than the experimental group and can practice if they want. At the end of the hospitalization, they will receive a paper document with global informations about physical exercises including a few simple exercises. Evaluations will be carried out in both arms at day 0, day 30 and day 90 from autograft. The post graft follow up will be done at the same time as the medical consultation and before the maintenance treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physical exercise arm
patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization. Furthermore, SMS will be regularly sent to remind them to practice
Physical exercises
patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization.
controlled arm
patients will be hospitalized in the same conditions than the experimental group and will be able to practice if they want.
Optional physical exercises
patients will be proposed for the physical exercises and will practice them if they want.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical exercises
patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization.
Optional physical exercises
patients will be proposed for the physical exercises and will practice them if they want.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* more than 18 years old
* Hospitalized for autologous stem cell transplantation
* First or second line therapy for multiple myeloma
* Chemotherapy regimen with melphalan
* Patient affiliated to the social security system
* Signed informed consent form
* Patient who have computer and internet connection at home
Exclusion Criteria
* Other haematological malignancies
* More than 2 treatment lines
* Other regimen of chemotherapy for autograft than melphalan
* Contraindication to physical exercises: uncontrolled arterial hypertension or diabetes, heart or respiratory failure, psycho-cognitive disorders that may compromise the physical exercises program
* dialyzed patient
* Adult patient under tutelage
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
University Hospital, Caen
OTHER
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
caroline delette, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens
Pierre Morel, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens
Fabrice Jardin, Pr
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Oana Brehar, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Vincent Camus, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Nathalie Cardinael, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Nathalie Contentin, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Marie-Laure Fontoura, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Carole Fronville Varnier, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Hélène Lanic, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Emilie Lemasle Hue, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Pascal Lenain, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Stéphane Lepretre, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Anna-Lise Menard, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Aspasia Stamatoullas-Bastard, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Hervé Tilly, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rouen
Gandhi L Damaj, Pr
Role: PRINCIPAL_INVESTIGATOR
CHU CAEN
Stéphane Cheze, MD
Role: PRINCIPAL_INVESTIGATOR
CHU CAEN
Margaret Macro, MD
Role: PRINCIPAL_INVESTIGATOR
CHU CAEN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2018_843_0008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.